MISSISSAUGA, Ontario, May 23, 2011 /PRNewswire/ — CardioGenics
Holdings Inc. (CGNH: OTCB) announced today that Dr. Yahia Gawad,
CEO of CardioGenics will be presenting at the 7th Annual Spring
Growth Stock Conference hosted by Security Research Associates,
Inc.  The conference will be held on Tuesday, May 24th at the
Omni Hotel in San Francisco.  

Conference attendees will include a select group of
institutional portfolio managers and analysts, and will feature
CEOs and CFOs from some of the fastest growing companies in the
technology and life sciences sectors.  SRA has arranged for
webcasting of company presentations during this event. To access
the lobby page for the webcast of presenting companies please go
to: http://www.wsw.com/webcast/sra12/

“We are very pleased to be invited to present at Security
Research Associates’ 7th Annual Spring Growth Stock Conference,”
stated Dr. Yahia Gawad, CEO of CardioGenics. “Each year SRA brings
together at their conference an interesting array of microcap and
smallcap companies from the life sciences and technology sectors
and we are looking forward to presenting CardioGenics’ exciting
developments to the portfolio managers and analysts who have been
invited to attend the conference,” continued Dr. Gawad.

About CardioGenics Holdings Inc.

Through its operating subsidiaries, the Company develops
ultra-sensitive analyzers and other products targeting the
immunoassay segment of the Point-Of-Care IVD testing market. It has
developed the QL Care™ Analyzer, a proprietary and
ultra-sensitive Point-Of-Care immuno-analyzer, which will run a
number of diagnostic tests under development, the first of which
will be a series of cardiovascular diagnostic tests. As part of its
core proprietary technology, the Company has also developed a
proprietary method for silver coating paramagnetic microspheres (a
fundamental platform component of

‘/>”/>

SOURCE